Pharmaceutical manufacturer Adcock Ingram will be reopening its critical care manufacturing facility this week after an employee tested positive for COVID-19, subsequently other employees has been tested for the virus and have come out negative. Joining CNBC Africa for more is Andy Hall, CEO of Adcock Ingram.